The Pitch Deck Playbook · Post 4 of 6
Investors don’t fund science. They fund people. But in most biotech pitch decks, the team slide is a résumé dump that tells the investor nothing about why this team can actually pull it off.
Investors don’t fund companies. They fund people.
You’ve heard this before. It gets repeated so often that it’s lost its weight. But it’s still true, and the team slide is where founders prove they either understand this or don’t.
In my experience designing 200+ decks over 20 years, the team slide is consistently the one founders spend the least time on and the one investors spend the most time scrutinizing. In the Hunger Arc, it’s the cheese course: quieter than the traction data, but essential. This is where the investor stops evaluating the science and starts evaluating the people.
And most founders serve it cold.
Three or four headshots. Name, title, a list of previous companies. Maybe a university crest. It looks like a corporate About page, reads like a LinkedIn profile, and tells the investor absolutely nothing about why this team is the right team to solve this specific problem.
What investors are actually looking for
When an investor looks at your biotech team slide, they’re not asking whether your CSO has impressive credentials. They’re asking: does this person’s specific experience make them uniquely qualified to advance this specific science?
A PhD in oncology is impressive in a vacuum. A PhD in oncology who spent eight years developing the exact antibody platform your company is built on? That’s not a credential. That’s a reason.
An ex-Pfizer regulatory lead is a strong hire. An ex-Pfizer regulatory lead who shepherded an orphan drug through the same pathway you’re targeting? That’s a story an investor remembers on the flight home.
The difference between a credential and a story is the connection to your company’s mission. And most team slides don’t make that connection.
A PhD in oncology is impressive in a vacuum. A PhD in oncology who spent eight years developing the exact platform your company is built on? That’s not a credential. That’s a reason.
The one-sentence fix
For each team member, write one sentence that connects their background to the company’s mission. Not a bio. A reason.
Instead of:
“Dr. Priya Mehta, CSO. Previously Director of Biologics at Genentech. PhD Immunology, Johns Hopkins.”
Try:
“Priya spent 10 years developing monoclonal antibodies at Genentech, then watched her mother navigate a disease with no approved biologic. She designed our lead candidate.”
Same person. Same credentials. But the second version tells the investor why Priya is here, why she cares, and why her specific experience makes her the right scientist to build this specific therapy. The investor doesn’t see a résumé. They see a motivated human with a direct line between their past and this company’s future.
Do this for every person on the slide. One sentence each. If you can’t draw a clear line between someone’s background and the company’s mission, that’s a signal worth paying attention to.
The power of the unexpected credential
Here’s something I’ve learned from my own career. My background is in industrial design. I studied adult education. I’m a certified pâtissier. I’ve worked in NGO fundraising, led creative for Pride Toronto, and run marketing at a boutique investment firm.
On paper, that’s a strange résumé. In practice, it’s exactly why I’m good at what I do. Building a great biotech pitch deck requires visual design, adult learning principles, emotional storytelling, financial communication, and the high-pressure dynamics of fundraising. Every piece connects.
Your team probably has people with non-obvious backgrounds that are actually differentiators. The VP of Clinical Ops who trained as a nurse and now designs patient-centric trial protocols. The CEO who started as a bench scientist and can still read a blot. These aren’t footnotes. They belong on the slide.
What to leave off
Stop thinking of the team slide as a headshot grid. Think of it as a visual argument for why this group of humans is the best possible team to advance this science.
Include: a good photo (not a corporate headshot), a clear title, and the one-sentence connection. That’s it.
Leave off: university crests (unless the research originated there), lengthy publication lists, advisory boards with ten names and no context. Investors aren’t hiring these people. They’re betting on them. Make the bet feel good.
If you have a strong scientific advisory board, give them one clean line: the names, their affiliations, and one sentence about what they collectively bring. Don’t give each advisor a headshot and a paragraph. The SAB supports the bet. The core team is the bet.
Investors aren’t hiring these people. They’re betting on them. Make the bet feel good.
The cheese course, not the main course
Remember where the team slide sits in the Hunger Arc. It’s the cheese course. It comes after the data, after the pipeline, after you’ve proven the science is real. By the time the investor reaches this slide, they already believe in the opportunity. Now they need to believe in the people.
A cheese course that tries to be a main course overwhelms the palate. Keep it clean, keep it warm, and let the one-sentence connections do the work. The investor should finish this slide feeling reassured, not overloaded.
If you want someone to look at your team slide with fresh eyes, that’s what the One Hour Deck Review is for.
Next up in this series: There’s a slide that tells investors whether you actually know what you’re doing, and most founders skip it entirely. I’m going to show you how to build the one slide that makes investors feel safe writing the cheque.
Book a One Hour Deck Review →
Subscribe to the Playbook →